Namaxir (Methotrexate)

Methotrexate, the active ingredient in Namaxir, is an antimetabolite (folate antagonist) presented as a parenteral formulation for epidural, intra‑articular or intramuscular use. It is employed to treat rheumatoid arthritis, psoriasis, certain cancers and ectopic pregnancy in appropriate patients.

GNH USA supplies Namaxir as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methotrexate acts on rapidly dividing cells and modulates immune pathways, making it useful across several disease families.

- Rheumatoid arthritis: reduces joint inflammation and disease activity. - Psoriasis: improves skin lesions and decreases plaque formation. - Certain cancers (e.g., leukemia, lymphoma): inhibits tumor cell proliferation. - Ectopic pregnancy: terminates trophoblastic tissue and prevents further growth.

Methotrexate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea and vomiting. - Fatigue or general weakness. - Oral mucosal ulceration (mouth sores). - Transient elevation of liver enzymes. - Decreased white blood cell count. - Hair thinning or temporary alopecia.

Serious or Rare Side Effects: - Severe hepatic toxicity or fibrosis. - Pulmonary fibrosis or interstitial pneumonitis. - Life‑threatening bone marrow suppression. - Acute kidney injury. - Severe infections due to immunosuppression. - Anaphylactic or severe hypersensitivity reactions.

Methotrexate requires careful monitoring and specific safety measures.

- Pregnancy contraindication: avoid use in pregnancy (Category X). - Renal function: assess creatinine clearance before and during therapy. - Hepatic monitoring: perform regular liver function tests. - Hematologic surveillance: monitor complete blood counts frequently. - Alcohol avoidance: limit or abstain to reduce liver risk. - Contraception: use effective methods during treatment and for several weeks after. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Methotrexate interacts with several drug classes that can alter its efficacy or safety.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase toxicity. - Trimethoprim‑sulfamethoxazole: potentiate bone marrow suppression. - Live vaccines: risk of severe infection. - Proton‑pump inhibitors (omeprazole): may reduce renal clearance. - High‑dose aspirin: heighten hepatotoxic risk.

Moderate Interactions (Monitor Closely): - Azathioprine or other immunosuppressants: additive myelosuppression. - Cyclosporine: increased nephrotoxicity. - Phenytoin: may lower methotrexate levels. - Sulfonamide antibiotics: enhance hematologic effects. - Alcohol: exacerbates liver injury.